Nu-Med Plus (NUMD) Share-based Compensation Growth (5y) (2017 - 2022)
Nu-Med Plus (NUMD) Share-based Compensation Growth (5y) (2017 - 2022) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn |
| 10 | Nu-Med Plus | 2.03 Mn | 2.02 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2022 | 7.00% |
| Dec 31, 2021 | -34.40% |
| Dec 31, 2020 | -4.55% |
| Sep 30, 2020 | -30.30% |
| Mar 31, 2020 | 161.49% |
| Dec 31, 2019 | -47.55% |
| Sep 30, 2019 | -24.16% |
| Jun 30, 2019 | -28.97% |
| Mar 31, 2019 | 69.03% |
| Sep 30, 2018 | 70.00% |
| Dec 31, 2017 | -20.03% |
| Sep 30, 2017 | -5.91% |